| Item number | Description | Size (mm) | Length (mm) | Units per box |
|---|---|---|---|---|
| NONB5STF | Standard fixation cannula | 5 | 100 | 6 |
| NONB5SHF | Short fixation cannula | 5 | 70 | 6 |
| NONB5LGF | Long fixation cannula | 5 | 150 | 6 |
| NONB8STF | Standard fixation cannula | 8 | 100 | 6 |
| NONB11STF | Standard fixation cannula | 11 | 100 | 6 |
| NONB12STF | Standard fixation cannula | 12 | 100 | 6 |
| NONB12STS | Standard smooth cannula | 12 | 100 | 6 |
| NONB12SHF | Short fixation cannula | 12 | 70 | 6 |
| NONB12LGF | Long fixation cannula | 12 | 150 | 6 |
| NONB15STF | Standard fixation cannula | 15 | 100 | 6 |
| NONB15LGF | Long fixation cannula | 15 | 150 | 6 |
Bladeless trocars
VersaOne™ bladeless trocar
<p>The VersaOne™ bladeless trocar is intended for use in a variety of endoscopic procedures to create and maintain a port of entry.</p>
Features
The advantages of the bladeless trocar include:
- Unique dolphin-nose tip to facilitate smoother insertion for easier trocar placement†,1
- Ergonomic design to provide control and comfort during laparoscopic procedures‡,2
Ordering information
Similar products
-
Mini Step™ access systemThe Mini Step™ access system is intended for abdominal and thoracic procedures and offers dilatation access to cavities for diagnostic and operative purposes.
-
Step™ access systemThe Step™ access system is intended for abdominal and thoracic procedures and offers dilatation access to cavities for diagnostic and operative purposes.
-
VersaStep™ bladeless trocarThe VersaStep™ bladeless trocar is available in multiple sizes to enable access during laparoscopic and minimally invasive procedures.
TM* Third-party brands are trademarks of their respective owners.
† In a porcine model (n = 24 per test group), VersaOne™ (model ONB12STF) had significantly less penetration force (p<0.0015) compared to Applied Kii™* (CTR73). Preclinical results may not correlate with clinical performance in humans.
‡ Based on a survey of 52 surgeons' preferences.
- Based on internal report RE00365735, periscope II in vivo penetration/fixation competitive EBM testing. October 2021.
- Based on Eichler and Lieberman market research. March 2013.